11. Heart Health 101: Cardiovascular Disease, Longevity, Lp(a) and Smarter Testing

11. Heart Health 101: Cardiovascular Disease, Longevity, Lp(a) and Smarter Testing

Heart Health & Longevity: Cardiovascular Disease, Lp(a), and Smarter Testing

Summary

Cardiovascular disease (CVD) remains the #1 killer in America—claiming one life every 36 seconds and costing the U.S. economy over $365 billion annually. But here’s the hopeful truth: much of it is preventable.

In this episode, Drs. Nisha and Vikas Patel take you on a practical, evidence-based deep dive into heart health. From sobering statistics and risk factors to advanced screening tools and new therapies, this conversation will leave you with a clear roadmap for protecting your most vital organ. And yes, there’s humor too—because talking about stents, statins, and stress tests doesn’t have to be dry.

What You’ll Learn:
  1. The Scope of the Problem
  • 655,000 Americans die annually from CVD.
  • 126 million adults are living with some form of CVD.
  • Annual cost exceeds $365 billion (medical care + lost productivity).

  1. Risk Factors
  • Non-modifiable: age, sex, genetics, family history.
  • Modifiable: high blood pressure, high LDL/ApoB, diabetes, smoking, inactivity, and excess visceral fat.
  • Why hypertension is called the “silent killer” and why new guidelines lowered the bar to 130/80.
  • Why we now prioritize ApoB over LDL cholesterol.

  1. Pathophysiology Simplified
  • How atherosclerosis develops from endothelial damage to plaque rupture.
  • Why the most dangerous plaques aren’t always the most narrowed.
  • The role of inflammation and what the CANTOS trial taught us.

  1. Advanced Screening Tools
  • ApoB testing for particle number.
  • Coronary artery calcium (CAC) scoring: score of 0 = low risk; >400 = high risk.
  • CT angiography: visualizing both calcified and non-calcified plaque.
  1. The Lipoprotein(a) Deep Dive
  • Elevated in ~20% of people, but rarely measured.
  • Doubles coronary heart disease risk, increases risk of aortic stenosis and stroke.
  • Almost entirely genetic, unaffected by diet/exercise/statins.
  • New therapies in clinical trials could reduce levels by 80–90%.
  • Until then: double down on controllable risk factors.
  1. Evidence-Based Risk Reduction
  • Diet: Mediterranean diet lowers major CV events by 30% (PREDIMED trial).
  • Exercise: 150 minutes/week of moderate activity = 30% lower CV mortality.
  • Medications:

    • Statins: 20–25% reduction in CV events.
    • Ezetimibe & PCSK9 inhibitors: powerful LDL lowering, though costly.
    • Blood pressure meds: effective across multiple classes—choice matters less than control.
  1. Practical Implementation
  • Know your numbers: LDL, ApoB, Lp(a), BP, A1c, VO₂ max, visceral fat.
  • Get a baseline with advanced screening (DEXA, CAC, CT).
  • Build habits: strength training + cardio, Mediterranean-style nutrition, stress and sleep hygiene.
  • Medications when appropriate—don’t let “perfect” be the enemy of good.
Call to Action

CVD prevention is not just possible—it’s powerful. Know your numbers, track your risks, and take proactive steps to protect your heart.

At MD Longevity Lab, we use tools like VO₂ max testing, full-body DEXA, ApoB and Lp(a) labs, and calcium scoring to create personalized heart health strategies. Don’t wait for a cardiac event—get ahead of the game.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(33)

33. Your Health Is Their Inheritance: What Happens to Your Kids When You Don't Take Care of Yourself

33. Your Health Is Their Inheritance: What Happens to Your Kids When You Don't Take Care of Yourself

The longevity space has earned a reputation for being self-absorbed — biohacker bros optimizing their bloodwork while the rest of us live actual lives. In a word: selfish. This episode is the rebuttal...

2 Jul 55min

32. The Muscle Playbook: Preservation, Building, and Progressive Overload

32. The Muscle Playbook: Preservation, Building, and Progressive Overload

There is more conflicting advice about muscle out there than almost any other topic in fitness — what to eat, how much to lift, how often, how heavy, whether older adults should even be lifting at all...

18 Jun 1h 10min

31. The Evidence-Based Supplement Guide: Cutting Through the $60 Billion Noise

31. The Evidence-Based Supplement Guide: Cutting Through the $60 Billion Noise

The supplement industry is a $60 billion business with almost no regulatory oversight. Three out of four American adults take at least one. Almost none of them know what's actually in the bottle.In th...

4 Jun 56min

30. The Delay Game: How Health Insurance Abandoned Your Healthcare & Why The Long Game of Prevention Belongs to You

30. The Delay Game: How Health Insurance Abandoned Your Healthcare & Why The Long Game of Prevention Belongs to You

The American health insurance industry is no longer in the business of paying for your healthcare. It is in the business of delaying it — long enough that someone else has to pay. Usually Medicare. Wh...

21 Mai 49min

29. The Statin You Fear vs. The Peptide You Trust: The Credibility Crisis in American Healthcare

29. The Statin You Fear vs. The Peptide You Trust: The Credibility Crisis in American Healthcare

This episode is a follow-up and expansion of Vikas's recent piece in STAT News on the same topic.Mention statins at a dinner party and you'll get muscle pain, brain fog, and Big Pharma conspiracies. M...

7 Mai 49min

28. Can You Out-Run Your Cocktail? Exercise, Alcohol, and the Science of Damage Control

28. Can You Out-Run Your Cocktail? Exercise, Alcohol, and the Science of Damage Control

Episode Title: Can You Out-Run Your Cocktail? Exercise, Alcohol, and the Science of Damage ControlCan exercise protect you from the damage alcohol does to your body? Drs. Vikas and Nisha Patel break d...

23 Apr 49min

27. GLP-1 Series, Part 2: Muscle Loss, Weight Regain, and the Protocol That Actually Works

27. GLP-1 Series, Part 2: Muscle Loss, Weight Regain, and the Protocol That Actually Works

The real conversation about GLP-1 medications doesn't end with the prescription. Part 2 is where we get into the uncomfortable truths — the data on muscle loss, the biology of weight regain, the patie...

9 Apr 1h 2min

26. GLP-1 Series, Part 1: The Biology, the Drugs, and Why the Benefits Go Deeper Than the Scale

26. GLP-1 Series, Part 1: The Biology, the Drugs, and Why the Benefits Go Deeper Than the Scale

📝 Free Substack: mdlongevitylab.substack.com🌐 mdlongevitylab.com📸 @mdlongevitylab🎧 Subscribe, leave a 5-star review, and share this episode with one person who needs to hear it.GLP-1 medications a...

26 Mar 52min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
leger-om-livet
psykodrama
rss-skravla-gar
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-garne-damer
rss-kunsten-a-leve
foreldreradet
g-punktet
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
treningsprat
kjed-deg-i-sovn-verdens-kjedeligste-podcast
hjernesterk
helsetipspodden
sinnsyn